Editor

Stanley M. Fineman, MD
Marietta, GA

Assistant Editors

Anthony Montanaro, MD
Portland, OR

Bradley E. Chipps, MD
Sacramento, CA

Chitra Dinakar, MD
Kansas City, MO

Vivian Hernandez-Trujillo, MD
Miami, FL

David A. Khan, MD
Grapevine, TX

Gerald B. Lee, MD
Atlanta, GA

John J. Oppenheimer, MD
Denville, NJ

Disclosures

Stanley M. Fineman, MD, Editor-in-Chief

  • Speaker: AstraZenca, Boehringer Ingelheim, Shire
  • Contracted Research: Aimmune, DBV, Shire, Regeneron

 Bradley E. Chipps, MD, Assistant Editor

  • Advisory Board: AstraZeneca, Boehringer Ingelheim, Circassia, Genentech, Novartis, Regeneron, Sunovian, Teva
  • Consultant: AstraZeneca, Boehringer Ingelheim, Circassia, Genentech, Novartis, Regeneron, Sunovian, Teva
  • Speaker/Teacher: AstraZeneca, Boehringer Ingelheim, Circassia, Genentech, Novartis, Regeneron, Sunovian, Teva

Chitra Dinakar, MD, Assistant Editor

  • No relevant disclosures

Vivian Hernandez-Trujillo, MD, Assistant Editor

  • Consultant/Advisor: CSL Behring
  • Honoraria: Bayer, Meda, Merck
  • Research Funding: CSL Behring

David A. Khan, MD, Assistant Editor

  • Speaker/Teacher: Genentech
  • Consultant/Advisor: Aimmune

Gerald B. Lee, MD, Assistant Editor

  • No relevant disclosures

John J. Oppenheimer, MD, Assitant Editor

  • Advisory Board: AstraZeneca, GlaxoSmithKline, Novartis, Sanofi
  • Consultant: AstraZeneca, DBV, GlaxoSmithKline, Sanofi